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Although a filling defect within the ureter is the most common finding with ureteral transitional cell
carcinomas (TCCs), little is known about the correlation between filling defect patterns and pathologic
findings. This study was conducted to address this. Between January 1995 and January 2003, 126
pathologically confirmed TCCs of the ureter were included in our study. We classified urographic filling
defects into four patterns: ovoid, polypoid, infiltrating, and plaque-like. The correlation between different
filling defect patterns and pathologic findings was assessed using Pearson’s Chi-squared and logistic
regression methods. There were 28 (22%) ovoid filling defects, 42 (33%) polypoid filling defects, 37 (29%)
infiltrating filling defects, and 19 (15%) plaque-like filling defects. Infiltrating and plaque-like filling defects
were significantly associated with more advanced disease compared to ovoid and polypoid filling defects
(odds ratio, 6.75; 95% confidence interval, 3.04–14.98; p < 0.0001). Our results suggest that filling defect
presentations may signify different invasive behavior among TCCs. The distribution of ovoid, polypoid,
infiltrating, and plaque-like filling defect patterns is significantly different between superficial and
advanced ureteral TCCs. We suggest that classifying the filling defect patterns of ureteral TCCs may provide
important preoperative information for planning treatment and predicting outcome.
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Transitional cell carcinoma (TCC) of the ureter is not
common worldwide, representing only 1% of all
genitourinary malignancies [1–3]. However, ureteral
carcinoma is relatively common in Taiwan [4–7]. Urographic
examinations, including intravenous pyelography (IVP),
retrograde pyelography (RP), and antegrade pyelography
(AP), are important tools in detecting the tumor and defining
its extent and location [1,3,8]. The most common
radiographic finding in ureteral carcinoma is the presence
of a filling defect within the ureter [9,10]. Although various
filling defect patterns have been reported with ureteral
TCCs [1,8,11], only a few studies have focused on the
association between filling defect patterns and pathologic
findings. Here, we report a large series of ureteral TCCs and
analyze the correlation between filling defect patterns and
pathologic staging.
MATERIALS AND METHODS
Between January 1995 and January 2003, patients at our
institution with histopathologically confirmed TCC of the
ureter and with complete radiographic and histologic data
Kaohsiung J Med Sci September 2003 • Vol 19 • No 9
Y.L. Lee, S.P. Huang, M.C. Shih, et al
448
were eligible for inclusion in the study. Computed
tomography was obtained in all cases and all patients
underwent at least one urographic examination (IVP, RP, or
AP). RP or AP was usually performed when IVP failed to
localize the lesion or when patients had renal insufficiency.
Urographic films were reviewed by an independent
radiologist (MCS) who was blinded to clinical and pathologic
data. Filling defects on urography were divided into four
patterns by their shape: ovoid, polypoid, infiltrating, or
plaque-like [11]. We defined ovoid as a single, rounded,
nodular, exophytic lesion (Figure A); polypoid as a papillary,
lobulated, exophytic lesion (Figure B); infiltrating as an
extensive, straggling, sessile, broad-based lesion (Figure
C); and plaque-like as a thickened-wall constriction with
overhanging edges and strand-like contrast filling
appearance (Figure D). Surface regularity, goblet sign,
stipple sign, concomitant calcification, and pseudo-
diverticulum were also recorded. We used the most clearly
defined images from IVP, RP, and AP to categorize the
patterns of the filling defects.
Pathologic staging was based on the classifications
proposed by Batata et al [12]: stage A is defined as
submucosal infiltration, stage B as muscular invasion, stage
C as periureteral involvement, and stage D as extension to
adjoining structures, regional lymph node metastases, or
distant spread. Stage A was considered superficial disease
because it was limited to the submucosal layer. Stages B, C,
and D were considered advanced disease because invasion
reached at least the muscle.
Pearson’s Chi-squared and logistic regression methods
were used to examine the association between various
filling defect patterns and pathologic staging. Data are
presented as odds ratio (OR) and 95% confidence interval
(95% CI). A p value of less than 0.05 was considered
statistically significant. Data analysis was performed using
SPSS version 8.01 (SPSS Inc., Chicago, IL, USA).
RESULTS
Of 134 histopathologically confirmed cases of TCC of the
ureter between January 1995 and January 2003, eight cases
were excluded due to incomplete radiographic and
histologic data. A total of 126 cases were enrolled in the
study. Mean age at diagnosis was 66.5 years (range, 26–85).
There were more male (54%) than female patients (Table 1).
Most tumors were located in the upper third of the ureter;
the left ureter was more frequently involved than the right
ureter. There were similar numbers of superficial and
Figure. Different filling defect patterns on urography: (A) ovoid filling
defect; (B) polypoid filling defect; (C) infiltrating filling defect;
(D) plaque-like filling defect.
advanced tumors (Table 1). Gross hematuria was the most
common symptom, occurring in 70% of patients. Flank
pain, urinary frequency, dysuria, lower abdominal pain,
and fever were less common symptoms. Seven patients
(6%) were asymptomatic and were diagnosed incidentally
on ultrasonography after presentation with hydronephrosis.
Filling defect patterns were determined by RP (80 cases,
63%), AP (39 cases, 31%), and IVP (7 cases, 6%). Polypoid
filling defects were most common (33.3%), followed by
infiltrating (29.4%), ovoid (22.2%) and plaque-like (15.1%)
filling defects (Table 2). Most lesions (81.7%) manifested
with an irregular surface. The goblet sign was found in
30.2% of lesions and the stipple sign in 19.8%. Seven lesions
(5.6%) showed concomitant calcification. There was no
pseudodiverticulum.
The distribution of ovoid, polypoid, infiltrating, and
plaque-like filling defects was significantly different between
superficial disease and advanced disease (Chi-squared test,
 A  B
C D
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DISCUSSION
Ureteral carcinomas are mostly located in the lower third of
the ureter [12–14]. In northern Taiwan, interestingly, Yang
et al documented an unusually high incidence of upper
urinary tract urothelial carcinoma and suggested that
geographic factors or genetic predisposition might
contribute to this phenomenon [4]. Our data show that the
upper third of the ureter is most frequently involved in
ureteral TCCs in southern Taiwan. The possible cause of
this finding in southern Taiwan is undetermined. Various
authors consider that the high incidence of upper urinary
tract carcinomas in southern Taiwan is due to the fact that
it is an area that is endemic for blackfoot disease [5–7].
Evidence suggests that the arsenic content and fluorescent
substances in artesian well water are a possible etiology in
blackfoot-endemic areas [15–19], but further investigation
is needed to determine whether this is so. There was no
significant difference in filling defect presentations among
the various locations of ureteral carcinomas in our study.
IVP, RP, and AP are inexpensive and are examinations
which can be easily performed to detect ureteral tumors and
define their extent and location [1,3,8]. IVP is the primary
initial examination for ureteral lesions, but only 6% of the
tumors in our study could be clearly seen with their filling
defect on IVP films. RP and AP films usually provide more
satisfactory delineation of the filling defect and the precise
filling defect pattern. RP and AP are more reliable than IVP
and clearly revealed approximately 94% of filling defects in
our study.
Both the goblet sign and stipple sign are specific features
of TCC of the ureter [20,21]. However, in our study, only
30.2% of cases had the goblet sign and only 19.8% had the
stipple sign. Wasserman et al reported that ureteral
pseudodiverticula were frequently associated with
uroepithelial malignancy [22], but we observed no
Table 2. Radiographic presentation of filling defects in 126
ureteral transitional cell carcinomas
n (%)
Shape
  Ovoid 28 (22.2)
  Polypoid 42 (33.3)
  Infiltrating 37 (29.4)
  Plaque-like 19 (15.1)
Surface
  Regular 23 (18.3)
  Irregular 103 (81.7)
Goblet sign 38 (30.2)
Stipple sign 25 (19.8)
Concomitant calcification 7 (5.6)
Pseudodiverticulum 0 (0)
Table 1. Demographic and disease characteristics of 126
patients with ureteral transitional cell carcinoma
n (%)
Male 68 (54)
Female 58 (46)
Right side 49 (39)
Left side 77 (61)
Location
  Upper third 50 (40)
  Middle third 24 (19)
  Lower third 49 (39)
  Whole length 3 (2)
Superficial disease (Stage A) 60 (48)
Advanced disease (Stages B, C, D) 66 (52)
     Stage B 26 (21)
     Stage C 21 (17)
     Stage D 19 (15)
Table 3. Comparison of filling defect patterns with tumor stage
Tumor stage
Filling defect pattern N Superficial disease (A) Advanced disease (B, C, D)
n (%) n (%)
Ovoid 28 20 (71)   8 (29)
Polypoid 42 27 (64) 15 (36)
Infiltrating 37   9 (24) 28 (76)
Plaque-like 19   4 (21) 15 (79)
Chi-squared test, p < 0.0001.
p < 0.0001) (Table 3). Infiltrating and plaque-like filling
defects were significantly associated with advanced disease
(OR, 6.75; 95% CI, 3.04–14.98; p < 0.0001) (Table 4).
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pseudodiverticulum in our study. The role of these specific
signs may need to be further elucidated.
The distribution of the four filling defect patterns was
statistically different between superficial and advanced
ureteral TCCs (p < 0.0001) (Table 3). Infiltrating and plaque-
like filling defects were significantly associated with
advanced TCCs, while ovoid and polypoid filling defects
were associated with superficial TCCs (OR, 6.75; 95% CI,
3.04–14.98; p < 0.0001) (Table 4). These findings are compa-
tible with the view that grossly polypoid and pedunculated
urothelial tumors are less invasive than sessile or flat lesions
[1]. Our results demonstrated that ureteral TCCs have
different invasive behavior and can be identified through
various filling defect patterns seen on urographic films.
Total nephroureterectomy with excision of the bladder
cuff is the standard therapy for ureteral malignancy [2,13,
14]. However, some authors advocate nephron sparing
surgery (NSS), including segmental ureteral resection or
transureteral endoscopic management in selected patients
[23–26]. These methods are controversial due to observed
recurrence rates of 12% to 50% [23–28]. To our knowledge,
no study has made recommendations on how to
preoperatively select patients for NSS for ureteral
carcinomas. Based on our urographic and pathologic
findings, we postulate that an aggressive treatment strategy
is needed for infiltrating and plaque-like filling defects due
to the possibility of invasive tumor behavior, whereas NSS
may be appropriate for less invasive ureteral TCCs with
ovoid and polypoid filling defects.
Our study has some limitations due to its retrospective
design. We attempted to reduce observer bias by blinding
one independent radiologist to the clinical and pathologic
data; the influence of observer bias should be minimal. A
large-scale, prospective clinical trial is warranted to further
validate our findings.
In conclusion, infiltrating and plaque-like filling defect
patterns are significantly associated with advanced TCCs
of the ureter, while ovoid and polypoid filling defect patterns
are associated with superficial TCCs of the ureter. The
filling defect pattern on urography may provide important
preoperative information to aid treatment planning and
deserves further investigation to validate its application in
clinical management.
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